Evidence map›Paper›PMID 24940173›Full record

ArticleNanoscale research letters2014

Reduced erbium-doped ceria nanoparticles: one nano-host applicable for simultaneous optical down- and up-conversions.

Nader Shehata, Kathleen Meehan, Ibrahim Hassounah, Mantu Hudait, Nikhil Jain, Michael Clavel, Sarah Elhelw, Nabil Madi

Abstract read
In one paragraph

Article in Nanoscale research letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Ultrasonically assisted surface modified CeOUltrasonics sonochemistry · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nader ShehataBradley Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, USA ; Department of Engineering Mathematics and Physics, Faculty of Engineering, Alexandria University, Alexandria, Egypt.
Kathleen MeehanBradley Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, USA.
Ibrahim HassounahInstitute for Critical Technology and Applied Science (ICTAS), Blacksburg, VA, USA.
Mantu HudaitBradley Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, USA.
Nikhil JainBradley Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, USA.
Michael ClavelBradley Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, USA.
Sarah ElhelwBradley Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, USA.
Nabil MadiCenter of Advanced Materials (CAM), Qatar University, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper introduces a new synthesis procedure to form erbium-doped ceria nanoparticles (EDC NPs) that can act as an optical medium for both up-conversion and down-conversion in the same time. This synthesis process results qualitatively in a high concentration of Ce(3+) ions required to obtain high fluorescence efficiency in the down-conversion process. Simultaneously, the synthesized nanoparticles contain the molecular energy levels of erbium that are required for up-conversion. Therefore, the synthesized EDC NPs can emit visible light when excited with either UV or IR photons. This opens new opportunities for applications where emission of light via both up- and down-conversions from a single nanomaterial is desired such as solar cells and bio-imaging.

Indexed as

Ceria nanoparticlesErbium dopantFluorescenceUp-conversion

Identifiers

PMID24940173
PMCPMC4038360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.